InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
63%
T+90 mean return
+21.1%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Galimi Francesco, SVP et Directeur Médical. Officer active across 1 company, notably Adicet Bio, Inc.. Cumulatively, 13 filings have been published. Activity tracked since 4 June 2021. The latest transaction was disclosed on 24 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
4,957 shares@ US$2.404.5% of flowCommon StockSEC:0000950170-24-008051:0
8,093 shares@ US$1.374.3% of flowCommon StockSEC:0001209191-23-051473:0
26,100 shares0Common StockSEC:0001209191-23-005044:0
7,933 shares@ US$14.2246.2% of flowCommon StockSEC:0001209191-22-052378:0
16,000 shares0Common StockSEC:0001209191-22-044904:0
7,621 shares@ US$5.970.051% mcap37.4% of flowCommon StockSEC:0001209191-22-023285:0
16,000 shares0Common StockSEC:0001209191-22-010483:0
16,000 shares0Common StockSEC:0001209191-22-006142:0
16,000 shares0Common StockSEC:0001209191-22-006142
80,000 shares0Common StockSEC:0001209191-21-059571
80,000 shares0Common StockSEC:0001209191-21-059571:0
6,983 shares@ US$5.970.043% mcap31.3% of flowCommon StockSEC:0001209191-21-039073:0
6,983 shares@ US$5.9714.1% of flowCommon StockSEC:0001209191-21-039073
13 of 13 declarations
About Galimi Francesco
Galimi Francesco serves as SVP & Chief Medical Officer at Adicet Bio, Inc. He is responsible for the company's medical strategy and clinical research. His role is essential in ensuring that products meet safety and efficacy standards.
